Skip to main content

ADVERTISEMENT

Jolynn Tumolo

News
11/22/2022
A 4-year study revealed the effects of long-term, continuous dupilumab treatment in patients with moderate-to-severe atopic dermatitis.
A 4-year study revealed the effects of long-term, continuous dupilumab treatment in patients with moderate-to-severe atopic dermatitis.
A 4-year study revealed the...
11/22/2022
First Report Managed Care
News
12/15/2022
The study involved 15,522 patients discharged to skilled nursing facilities that were ranked below average, average, or above average by the Centers for Medicare & Medicaid Services.
The study involved 15,522 patients discharged to skilled nursing facilities that were ranked below average, average, or above average by the Centers for Medicare & Medicaid Services.
The study involved 15,522...
12/15/2022
Annals of Long-Term Care
News
08/04/2022
The FDA recently granted Abbott a breakthrough device designation to investigate the use of its deep brain stimulation system for patients with treatment-resistant depression, a form of major depressive disorder.
The FDA recently granted Abbott a breakthrough device designation to investigate the use of its deep brain stimulation system for patients with treatment-resistant depression, a form of major depressive disorder.
The FDA recently granted Abbott...
08/04/2022
Psych Congress Network
News
02/13/2023
In both adults with and without ADHD, social support may protect against symptoms of depression and anxiety, according to study findings published in the Journal of Attention Disorders.
In both adults with and without ADHD, social support may protect against symptoms of depression and anxiety, according to study findings published in the Journal of Attention Disorders.
In both adults with and without...
02/13/2023
Psych Congress Network
News
02/28/2023
The proposed biosimilar natalizumab matches reference natalizumab for efficacy, safety, and immunogenicity in patients with relapsing-remitting MS.
The proposed biosimilar natalizumab matches reference natalizumab for efficacy, safety, and immunogenicity in patients with relapsing-remitting MS.
The proposed biosimilar...
02/28/2023
Neurology
News
03/31/2023
The risk of major depression in both men and women increases with the number of family members with major depression, study finds.
The risk of major depression in both men and women increases with the number of family members with major depression, study finds.
The risk of major depression in...
03/31/2023
Psych Congress Network
News
05/04/2023
A Class II recall has been issued for cartons of pantoprazole sodium injections due to deviations from Current Good Manufacturing Practices.
A Class II recall has been issued for cartons of pantoprazole sodium injections due to deviations from Current Good Manufacturing Practices.
A Class II recall has been...
05/04/2023
Pharmacy Learning Network
News
06/09/2023
A Class I recall has been issued for over-the-counter pediatric cough medicine due to a product mix-up.
A Class I recall has been issued for over-the-counter pediatric cough medicine due to a product mix-up.
A Class I recall has been issued...
06/09/2023
Pharmacy Learning Network
News
03/16/2023
Viral infections can be the most significant morbidity in some patients with primary immunodeficiency disease, researchers say.
Viral infections can be the most significant morbidity in some patients with primary immunodeficiency disease, researchers say.
Viral infections can be the most...
03/16/2023
Rheumatology & Arthritis
News
08/28/2023
In a recent study, older adults with Parkinson disease exhibited comparable patterns of potentially inappropriate medication use after hospitalization for serious injuries compared to those hospitalized for other reasons.
In a recent study, older adults with Parkinson disease exhibited comparable patterns of potentially inappropriate medication use after hospitalization for serious injuries compared to those hospitalized for other reasons.
In a recent study, older adults...
08/28/2023
Annals of Long-Term Care